146 related articles for article (PubMed ID: 11916752)
1. Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients.
Wood LG; Fitzgerald DA; Gibson PG; Cooper DM; Garg ML
Am J Clin Nutr; 2002 Apr; 75(4):668-75. PubMed ID: 11916752
[TBL] [Abstract][Full Text] [Related]
2. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function.
Wood LG; Fitzgerald DA; Lee AK; Garg ML
Am J Clin Nutr; 2003 Jan; 77(1):150-9. PubMed ID: 12499335
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in cystic fibrosis: dietary and metabolic factors.
Wood LG; Fitzgerald DA; Gibson PG; Cooper DM; Collins CE; Garg ML
J Am Coll Nutr; 2001 Apr; 20(2 Suppl):157-65. PubMed ID: 11349939
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress during acute respiratory exacerbations in cystic fibrosis.
McGrath LT; Mallon P; Dowey L; Silke B; McClean E; McDonnell M; Devine A; Copeland S; Elborn S
Thorax; 1999 Jun; 54(6):518-23. PubMed ID: 10335006
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
[TBL] [Abstract][Full Text] [Related]
7. Consumption of reduced-fat products: effects on parameters of anti-oxidative capacity.
Velthuis-te Wierik EJ; van den Berg H; Weststrate JA; van het Hof KH; de Graaf C
Eur J Clin Nutr; 1996 Apr; 50(4):214-9. PubMed ID: 8730607
[TBL] [Abstract][Full Text] [Related]
8. Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis.
Durieu I; Abbas-Chorfa F; Drai J; Iwaz J; Steghens JP; Puget M; Ecochard R; Bellon G
Eur Respir J; 2007 May; 29(5):958-64. PubMed ID: 17301094
[TBL] [Abstract][Full Text] [Related]
9. Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis.
Collins CE; Quaggiotto P; Wood L; O'Loughlin EV; Henry RL; Garg ML
Lipids; 1999 Jun; 34(6):551-6. PubMed ID: 10405967
[TBL] [Abstract][Full Text] [Related]
10. Total plasma antioxidant capacity in cystic fibrosis.
Lands LC; Grey VL; Grenier C
Pediatr Pulmonol; 2000 Feb; 29(2):81-7. PubMed ID: 10639197
[TBL] [Abstract][Full Text] [Related]
11. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma.
Wood LG; Fitzgerald DA; Gibson PG; Cooper DM; Garg ML
Lipids; 2000 Sep; 35(9):967-74. PubMed ID: 11026617
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress.
Brown RK; Wyatt H; Price JF; Kelly FJ
Eur Respir J; 1996 Feb; 9(2):334-9. PubMed ID: 8777973
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant deficiency in cystic fibrosis: when is the right time to take action?
Back EI; Frindt C; Nohr D; Frank J; Ziebach R; Stern M; Ranke M; Biesalski HK
Am J Clin Nutr; 2004 Aug; 80(2):374-84. PubMed ID: 15277158
[TBL] [Abstract][Full Text] [Related]
14. Treatment of pulmonary exacerbations of cystic fibrosis leads to improved antioxidant status.
Range SP; Dunster C; Knox AJ; Kelly FJ
Eur Respir J; 1999 Mar; 13(3):560-4. PubMed ID: 10232426
[TBL] [Abstract][Full Text] [Related]
15. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis.
Portal BC; Richard MJ; Faure HS; Hadjian AJ; Favier AE
Am J Clin Nutr; 1995 Apr; 61(4):843-7. PubMed ID: 7702029
[TBL] [Abstract][Full Text] [Related]
16. Dietary supplementation with aged garlic extract reduces plasma and urine concentrations of 8-iso-prostaglandin F(2 alpha) in smoking and nonsmoking men and women.
Dillon SA; Lowe GM; Billington D; Rahman K
J Nutr; 2002 Feb; 132(2):168-71. PubMed ID: 11823573
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E supplementation decreases basal levels of F(2)-isoprostanes and prostaglandin f(2alpha) in rats.
Södergren E; Cederberg J; Basu S; Vessby B
J Nutr; 2000 Jan; 130(1):10-4. PubMed ID: 10613758
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
Winklhofer-Roob BM; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Suter S; Shmerling DH
Pediatr Res; 1996 Jul; 40(1):130-4. PubMed ID: 8798258
[TBL] [Abstract][Full Text] [Related]
19. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis.
Hakim F; Kerem E; Rivlin J; Bentur L; Stankiewicz H; Bdolach-Abram T; Wilschanski M
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):347-53. PubMed ID: 17873748
[TBL] [Abstract][Full Text] [Related]
20. Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function.
Rust P; Eichler I; Renner S; Elmadfa I
Ann Nutr Metab; 2000; 44(1):30-7. PubMed ID: 10838464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
